Literature DB >> 25031761

Intravascular large B-cell lymphoma with pontine involvement successfully treated with R-CHOP therapy and intrathecal administration: a case report and review of literature.

Yasunobu Sekiguchi1, Asami Shimada1, Hidenori Imai2, Mutsumi Wakabayashi1, Keiji Sugimoto1, Noriko Nakamura3, Tomohiro Sawada3, Norio Komatsu4, Masaaki Noguchi1.   

Abstract

A 46-year-old man developed a fever and cough, and computed tomography showed multiple, nodular infiltrative shadows in lungs. He was diagnosed as having intravascular large B-cell lymphoma (IVLBCL). Brain magnetic resonance imaging (MRI, T2W1) showed an abnormal signal area in the pons, which was IVLBCL involvement. R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) therapy and intrathecal (I.T.) injection of methotrexate, cytarabine and prednisolone were selected. Complete remission (CR) was achieved and pontine involvement disappeared. A total of 8 courses of R-CHOP therapy and 4 courses of I.T. were performed. CR has been maintained for 1 year and 2 months.

Entities:  

Keywords:  CHOP therapy; Intravascular large B-cell lymphoma; central nervous system involvement; intrathecal administration; rituximab

Mesh：

Substances：

Year:  2014        PMID： 25031761      PMCID： PMC4097275     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN： 1936-2625


  10 in total

1.  Central nervous system involvement in intravascular large B-cell lymphoma: a retrospective analysis of 109 patients.

Authors:  Kazuyuki Shimada; Takuhei Murase; Kosei Matsue; Masataka Okamoto; Naoaki Ichikawa; Norifumi Tsukamoto; Nozomi Niitsu; Hiroshi Miwa; Hideki Asaoku; Hiroshi Kosugi; Ako Kikuchi; Morio Matsumoto; Yoshio Saburi; Yasufumi Masaki; Kazuhito Yamamoto; Motoko Yamaguchi; Shigeo Nakamura; Tomoki Naoe; Tomohiro Kinoshita
Journal:  Cancer Sci       Date:  2010-03-06       Impact factor: 6.716

2.  Can rituximab change the usually dismal prognosis of patients with intravascular large B-cell lymphoma?

Authors:  Andrés J M Ferreri; Giuseppina P Dognini; Silvia Govi; Roberto Crocchiolo; Maria Bouzani; Claudia R Bollinger; Michel D'Incan; Emmanuel Delaporte; Mehdi Hamadani; Fabrice Jardin; Magdalena Martusewicz-Boros; Mauro Montanari; Arpad Szomor; Emanuele Zucca; Franco Cavalli; Maurilio Ponzoni
Journal:  J Clin Oncol       Date:  2008-10-06       Impact factor: 44.544

Review 3.  Presentation and management of intravascular large B-cell lymphoma.

Authors:  Kazuyuki Shimada; Tomohiro Kinoshita; Tomoki Naoe; Shigeo Nakamura
Journal:  Lancet Oncol       Date:  2009-09       Impact factor: 41.316

4.  High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.

Authors:  Jorge E Romaguera; Luis Fayad; Maria A Rodriguez; Kristine R Broglio; Frederick B Hagemeister; Barbara Pro; Peter McLaughlin; Anas Younes; Felipe Samaniego; Andre Goy; Andreas H Sarris; Nam H Dang; Michael Wang; Virginia Beasley; L Jeffrey Medeiros; Ruth L Katz; Harish Gagneja; Barry I Samuels; Terry L Smith; Fernando F Cabanillas
Journal:  J Clin Oncol       Date:  2005-09-06       Impact factor: 44.544

5.  [Intravascular large B-cell lymphoma with pontine involvement successfully treated with R-hyper-CVAD/R-MTX-Ara-C regimen].

Authors:  Tomonori Nakazato; Kazuhito Suzuki; Ai Mihara; Yukinari Sanada; Sachiko Yoshida; Tsunayuki Kakimoto
Journal:  Rinsho Ketsueki       Date:  2010-02

6.  High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

Authors:  Andrés J M Ferreri; Michele Reni; Marco Foppoli; Maurizio Martelli; Gerasimus A Pangalis; Maurizio Frezzato; Maria Giuseppina Cabras; Alberto Fabbri; Gaetano Corazzelli; Fiorella Ilariucci; Giuseppe Rossi; Riccardo Soffietti; Caterina Stelitano; Daniele Vallisa; Francesco Zaja; Lucía Zoppegno; Gian Marco Aondio; Giuseppe Avvisati; Monica Balzarotti; Alba A Brandes; José Fajardo; Henry Gomez; Attilio Guarini; Graziella Pinotti; Luigi Rigacci; Catrina Uhlmann; Piero Picozzi; Paolo Vezzulli; Maurilio Ponzoni; Emanuele Zucca; Federico Caligaris-Cappio; Franco Cavalli
Journal:  Lancet       Date:  2009-09-18       Impact factor: 79.321

7.  Usefulness of FDG-PET to diagnose intravascular lymphomatosis presenting as fever of unknown origin.

Authors:  A Hoshino; E Kawada; T Ukita; K Itoh; H Sakamoto; K Fujita; N Mantani; T Kogure; J Tamura
Journal:  Am J Hematol       Date:  2004-07       Impact factor: 10.047

8.  Evaluation of organ involvement in intravascular large B-cell lymphoma by 18F-fluorodeoxyglucose positron emission tomography.

Authors:  Kazuyuki Shimada; Hiroshi Kosugi; Satoko Shimada; Hiroto Narimatsu; Yoshitsugu Koyama; Nobuaki Suzuki; Masaaki Yuge; Hironori Nishibori; Yosuke Iwata; Shigeo Nakamura; Tomoki Naoe; Tomohiro Kinoshita
Journal:  Int J Hematol       Date:  2008-05-22       Impact factor: 2.490

9.  Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan.

Authors:  Kazuyuki Shimada; Kosei Matsue; Kazuhito Yamamoto; Takuhei Murase; Naoaki Ichikawa; Masataka Okamoto; Nozomi Niitsu; Hiroshi Kosugi; Norifumi Tsukamoto; Hiroshi Miwa; Hideki Asaoku; Ako Kikuchi; Morio Matsumoto; Yoshio Saburi; Yasufumi Masaki; Motoko Yamaguchi; Shigeo Nakamura; Tomoki Naoe; Tomohiro Kinoshita
Journal:  J Clin Oncol       Date:  2008-05-27       Impact factor: 44.544

10.  Insufficiency of positron emission tomography and magnetic resonance spectroscopy in the diagnosis of intravascular lymphoma of the central nervous system.

Authors:  Nobuyuki Kawai; Masaki Okada; Reiji Haba; Yuka Yamamoto; Takashi Tamiya
Journal:  Case Rep Oncol       Date:  2012-07-03
  10 in total
  7 in total

1.  A 52-Year-Old Man With Seizures and Progressive Cerebrovascular Lesions.

Authors:  Christopher M McGraw; Sara C LaHue; Sean Ferris; Andrew W Bollen; Megan B Richie
Journal:  Neurohospitalist       Date:  2020-01-14

2.  Case Report: Intravascular Large B-Cell Lymphoma: A Clinicopathologic Study of Four Cases With Review of Additional 331 Cases in the Literature.

Authors:  Yingying Han; Qingjiao Li; Dan Wang; Lushan Peng; Tao Huang; Chunlin Ou; Keda Yang; Junpu Wang
Journal:  Front Oncol       Date:  2022-05-13       Impact factor: 5.738

3.  Long-term complete remission in a patient with intravascular large B-cell lymphoma with central nervous system involvement.

Authors:  Takeshi Sawada; Yasushi Omuro; Takeshi Kobayashi; Tunekazu Hishima; Fumiaki Koizumi; Yusuke Kanemasa; Tatsu Shimoyama; Eisaku Sasaki; Yoshiharu Maeda
Journal:  Onco Targets Ther       Date:  2014-11-18       Impact factor: 4.147

Review 4.  Intravascular Lymphoma in the CNS: Options for Treatment.

Authors:  Damir Nizamutdinov; Nitesh P Patel; Jason H Huang; Ekokobe Fonkem
Journal:  Curr Treat Options Neurol       Date:  2017-08-23       Impact factor: 3.598

5.  Retrospective study of intravascular large B-cell lymphoma cases diagnosed in Quebec: A retrospective study of 29 case reports.

Authors:  Vanessa Brunet; Sofia Marouan; Jean-Pierre Routy; Mohamed Amin Hashem; Vincent Bernier; Raynald Simard; Tony Petrella; Louis Lamarre; Gilles Théorêt; Christian Carrier; Hans Knecht; Isabelle Fleury; Michel Pavic
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

6.  A rare case of suspected intravascular large B-cell lymphoma forming nodular masses in the brain and around the prostate and seminal vesicle.

Authors:  Takuto Ogasawara; Yoshinori Ikehata; Ryuichi Kato; Noriomi Miyao; Yasuhiro Konishi; Shinichiro Kon
Journal:  Urol Case Rep       Date:  2018-02-07

7.  Intravascular Lymphoma with Progressive CNS Hemorrhage and Multiple Dissections.

Authors:  Ricky Chen; Gurjeet Singh; J Scott McNally; Cheryl A Palmer; Adam de Havenon
Journal:  Case Rep Neurol Med       Date:  2020-01-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.